-
Most Popular
Search Results
240 results for MJN
Pfizer Shares – 3 Pros, 3 Cons
Will a robust pipeline offset the loss of patent protection on key drugs?
Will Less Be More for Big Pharma?
Companies seem split on the asset selloff strategy.
The Dow Jones Transportation Average Is Showing Cracks
A breakdown isn’t imminent in the Dow Jones Transportation Average, but traders should keep a close eye on it.
Investing in Generation Y and the Next Great Baby Boom
Much like the Baby Boomers did more to shape the U.S. over the past 50 years, their children — Generation Y — will shape the…
52 Trades to Beat the Mutual Fund Slump
I’ve taken some of the guesswork out of stock picking for you by updating my ratings for these 52 stocks.
IPOs Investing – Why You Want to Invest in IPOs NOW!
We are looking at the hottest IPO market we have seen in years, and you’ll be kicking yourself if you miss out.
Mead Johnson Might Be One to Shed
Sales for Mead Johnson Nutrition’s baby food have been robust, but dividends and earnings growth have been mediocre.
50 Ways to Make Market Swings Work For You
With the stock market moving around in earnings season, now is the time to look through our buy and sell chart looking for ways to…
What To Make Of Tuesday’s Surprising Market Move
Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here’s our new research on 50 stocks in Portfolio…
12 Companies Increasing Dividends
Colgate-Palmolive, General Dynamics, Qualcomm and Staples are among this week’s top payout performers.
4 Blue Chips Ripe for Spin-Offs
Spin offs from Motorola and Marathon hint at four other companies that may have spinoffs soon – Pfizer, Yahoo, Symantec and GE.
47 Actions To Take On the Dow’s Big Dive
Earnings are the main driver of value in this market, and I’ve laid out my latest Portfolio Grader ratings for you to follow today….
Concerned About a Selloff? Here’s 68 Things You Can Do
Last week’s market drop caused concern among investors; there is no need to panic, and I’ll start you off with stocks to buy on the…
It May Be Time to Trim Away at Your Portfolio
The stock market is doing well for October, but its may be time to look through your portfolio in order to trim away some of…
Start Browsing Consumer Staples Stocks for Fairly Priced Defense
The consumer staples sector has underperformed in 2014, bringing valuations down to more reasonable levels. The time to buy the sector is nearing, but…
An Early Review of InvestorPlace’s 2012 Picks
How are we doing so far this year? Several writers provide the answer: Sometimes right on the money. Sometimes not.
Made in the USA Is Back – But It Depends on This One Thing
If there is one thing that always stays the same in this world, it’s that everything is always changing. This isn’t the same world it…
Why I Think the Fed Is Wrong – and How You Can Profit
The Federal Reserve concluded its latest policy meeting yesterday. And, as expected, it made no change to key interest rates. So, what’s keeping the Fed…
Louis Navellier Breaks Down the Big Fed News – and How to Profit Amid the Uncertainty
In his press conference, Fed Chair Jerome Powell reiterated the Fed’s “patient” approach, saying, “We think right now the appropriate thing to do is to…
‘Unprecedented’: What History Tells Us About the Word Taking Over Wall Street
It’s tempting to call everything President Donald Trump is doing “unprecedented.” To U.S.-focused investors, this all seems entirely new. But experienced investors will have seen similar…
Why Rich Men Are Buying the ‘Poor Man’s Gold’
Sure, gold is a great place to be in uncertain times, but investors shouldn’t forget about silver. It looks ready for its own upside.
Are These 2 Suit Stocks the Right Fit for You?
Men’s clothing retailers seem to decent bellwethers for the economy — but how do Jos. A. Bank, Men’s Wearhouse size up on their own?
8 – 10 of 240 results
